Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients
Clinical trial NCT05905380 · UNKNOWN
Trial details
- NCT number
- NCT05905380
- Sponsor
- University Hospital, Strasbourg, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-02
- Primary completion
- 2024-01-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.